A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
about
Giant Cell Arteritis - Beyond temporal artery biopsy and steroids.Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.[Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)].A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.The European Vasculitis Society 2016 Meeting Report.Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.Profile of tocilizumab and its potential in the treatment of giant cell arteritis.Giant Cell Arteritis: Practical Pearls and Updates.Current and emerging therapies in large-vessel vasculitis.Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy.Checks and Balances in Autoimmune Vasculitis.Investigational drugs in systemic vasculitis.Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.Personalized Biologic Therapy for Large Vessel Vasculitis: Comment on the Articles by Langford et al.FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.Current treatment options for psoriatic arthritis: spotlight on abatacept.
P2860
Q39293033-26D2066B-0047-444B-A281-962170AE7938Q40041736-C4AD2E82-C532-4F64-8E80-08B5688385B8Q40201293-3BD14FB3-C0D8-456F-B577-5FD6EBFEA21CQ40353901-8A9E506B-6A8C-4536-BE2E-C35B91302573Q47104190-4597B239-3350-49BC-9361-6B65645CDB96Q47107377-F6CD0B07-FAF7-4D15-8C7F-5CFBE1DFFAB1Q47583915-575AF964-2528-49DB-8482-7FD21AA5DD66Q49215677-806617CF-9AC4-406C-9B88-3B8F4A1CE88EQ49980652-F3811709-280F-4DCF-9FF8-C76B001BF9FAQ50082820-0BD4D2BC-EDAF-44EE-9D47-1740089F40E1Q50212292-1F32EBB3-AA32-48AF-A046-1CBD24A5C91FQ51764698-65F0AB9F-0790-4C56-8412-01822D59E6BAQ51834131-FEF9C648-D7AA-45C6-B2FD-94BE0C20800BQ52718727-0628E63B-35B6-443F-9120-75A3909B00F6Q53415506-4BC67F43-9BE2-49EA-ABA4-801F6D876AAEQ54238129-6A787539-3CB7-4B17-8301-843D6F06E7F5Q54943677-37C9AB7A-6079-4BBD-8AA7-22D0B17FE730Q55318901-0116C345-84C8-400A-B825-05892B26D38F
P2860
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A Randomized, Double-Blind Tri ...... tment of Giant Cell Arteritis.
@en
type
label
A Randomized, Double-Blind Tri ...... tment of Giant Cell Arteritis.
@en
prefLabel
A Randomized, Double-Blind Tri ...... tment of Giant Cell Arteritis.
@en
P2093
P2860
P356
P1476
A Randomized, Double-Blind Tri ...... tment of Giant Cell Arteritis.
@en
P2093
Antoine G Sreih
Carol A Langford
Carol A McAlear
Christian Pagnoux
Curry L Koening
David Cuthbertson
Gary S Hoffman
Jeffrey P Krischer
Kathleen McKinnon
Kenneth J Warrington
P2860
P304
P356
10.1002/ART.40044
P50
P577
2017-03-03T00:00:00Z